Analyst Ami Fadia works at LEERINK and is focused on the Healthcare sector with 252 price targets and ratings documented since 2018 spanning on 22 stocks. Analyst's average stock valuation to be materialised ratio is 43.71% with an average time for price targets to be met of 102.76 days.
Most recent stock forecast was given on AVDL, Avadel Pharmaceuticals plc at 21-Nov-2022.
Ami Fadia best performing recommendations are on MNK.
The best stock recommendation documented was for MNK at 9/6/2019. The price target of $2 was fulfilled within 3 days with a profit of $0.13 (6.95%) receiving and performance score of 23.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
3
$1.05 (53.85%)
5
1 months ago
5/24 (20.83%)
$8.19 (52.68%)
58
Sell
8 months ago
1/3 (33.33%)
$2.15 (12.62%)
300
Buy
9
$7.05 (361.54%)
10
9 months 2 days ago
2/8 (25%)
$4.49 (114.87%)
28
Buy
10
$8.05 (412.82%)
10
11 months 5 days ago
2/40 (5%)
$15.87 (150.77%)
3
Sell
5
11 months 21 days ago
8/12 (66.67%)
$1.07 (24.66%)
51
